Premium
Mammalian SIRT 2 inhibits keratin 19 expression and is a tumor suppressor in skin
Author(s) -
Ming Mei,
Qiang Lei,
Zhao Baozhong,
He YuYing
Publication year - 2014
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/exd.12323
Subject(s) - sirt2 , sirtuin , cancer research , biology , gene knockdown , keratinocyte , keratin , skin cancer , cancer , microbiology and biotechnology , gene , cell culture , genetics , acetylation
SIRT 2 is a member of the mammalian sirtuin family ( SIRT 1‐7). As compared with other sirtuins, SIRT 2 is found primarily in the cytoplasm. It regulates multiple physiological processes. However, the precise role of SIRT 2 in skin cancer remains unclear. Here, we show that SIRT 2 is downregulated in human skin cancer as compared with normal skin. SIRT 2 deletion increases tumor growth in mice. SIRT 2 knockdown upregulates the stem cell marker Keratin 19 (K19) in keratinocytes. In mice, SIRT 2 deletion up‐regulates K19 and K15 while it down‐regulates the differentiation marker Loricrin in both normal skin and tumors. In skin tumors but not normal skin, SIRT 2 deletion up‐regulates the stem cell marker CD 34 and increases the number of Ki67‐positive cells. These findings indicate that SIRT 2 is a tumor suppressor in the skin. Our findings add new insights into the role of SIRT 2 in the molecular pathogenesis of skin cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom